NCT05583188 2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4 Terminated
Galvanize Therapeutics, Inc.
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Hoffmann-La Roche
Tianjin Medical University Cancer Institute and Hospital